Quaker Wealth Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Quaker Wealth Management’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3	Hold	387	–	–	﹤0.01%	956
2026 Q2	$4	Hold	387	–	–	﹤0.01%	967
2026 Q1	$3	Hold	387	–	–	﹤0.01%	972
2025 Q4	$4	Hold	387	–	–	﹤0.01%	965
2025 Q3	$5	Hold	387	–	–	﹤0.01%	839
2025 Q2	$5	Buy	+387	New	+$5	﹤0.01%	866

Quaker Wealth Management's REVBW Position: Q3 2026 in Review

Quaker Wealth Management held its Revelation Biosciences Warrant (REVBW) position steady in Q3 2026 at 387 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #956.

Quaker Wealth Management first reported a position in REVBW in Q2 2025 and has held it in 6 quarters since. The position peaked at $5 in Q3 2025. 1 fund tracked by Wall St. Rank holds REVBW as of Q3 2026.

Quaker Wealth Management held 387 shares of Revelation Biosciences Warrant worth $3 as of Q3 2026.
Quaker Wealth Management left its Revelation Biosciences Warrant share count unchanged in Q3 2026.
Revelation Biosciences Warrant made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #956 holding.
Quaker Wealth Management first reported a position in Revelation Biosciences Warrant in Q2 2025 and has held it in 6 quarters since.
Quaker Wealth Management's Revelation Biosciences Warrant position peaked at $5 in Q3 2025.
1 fund tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.